ResMed | RMD - Ebitda

Stock Price
224.09
Daily Change
1.24 0.56%
Monthly
-13.24%
Yearly
5.03%
Q2 Forecast
217.34

ResMed reported $547.48M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Ansell USD 185.8M 7M Dec/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 19.86M 2.06M Dec/2025
Baxter International USD 426M 36M Sep/2025
Cochlear AUD 306.4M 13.5M Dec/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
CSL USD 3.13B 1.17B Dec/2025
Dexcom USD 422.2M 53.8M Dec/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
Fisher Paykel Healthcare NZD 364M 78.5M Jun/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Haemonetics USD 115.53M 9.22M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
Idexx Laboratories USD 391.47M 17.97M Sep/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 104.21M 25.76M Dec/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
Masimo USD 91.9M 19.9M Sep/2025
Medtronic USD 2.93B 482M Dec/2025
Philips EUR 738M 9M Sep/2025
Ramsay Health Care AUD 1.12B 10.6M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
Sigma Healthcare AUD 19.96M 5.15M Jul/2024
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Steris USD 389.7M 22.5M Sep/2025
Teleflex USD -328.81M 536.43M Sep/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025